跳至主要内容
临床试验/NCT06316401
NCT06316401已完成不适用

Endoscopic Submucosal Dissection of Large Recto-sigmoid Lesions Under Spinal Anesthesia

Azienda USL Modena1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
Safety of ESD under SA

研究概览

简要总结

The investigators collected data on all consecutive patients who underwent ESD for recto-sigmoid laterally spreading tumors (LSTs) >35 mm under SA between January 2021 and March 2024. The investigators evaluated the technical success and safety of SA in terms of ARAEs, and pain, measured via visual assessment scale (VAS).

详细描述

Background and study aim: Endoscopic submucosal dissection (ESD) of large colorectal lesions requires the patient to be in a still position for a long time. Both deep sedation and general anesthesia carry a substantial risk of anesthesia-related adverse events (ARAEs), especially in frail patients. Conversely, mild-to-moderate sedation does not prevent involuntary movements of the patient. Spinal anesthesia (SA) is a safe and simple technique that provides analgesia and motor block without systemic drug administration or orotracheal intubation. As the use of SA in colorectal endoscopic resections has not been described so far, we aimed to evaluate the feasibility and performance of SA in large (>35 mm) recto-sigmoid lesion ESD.

Patients and methods: The investigators collected data on all consecutive patients who underwent ESD for recto-sigmoid laterally spreading tumors (LSTs) >35 mm under SA between January 2021 and March 2024. The investigators evaluated the technical success and safety of SA in terms of ARAEs, and pain, measured via visual assessment scale (VAS). The secondary endpoints were as follows: intra- and post-procedural need for additional opioid or other analgesic drug administration, ESD-related adverse eventss, length of hospital stay, and median ESD duration.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age ≥18 years
  • American Society of Anaesthesiologists (ASA) score I-IV
  • ability to give informed consent

排除标准

  • age <18 years
  • ASA score V
  • allergy to medications used for spinal anesthesia
  • pregnancy
  • breastfeeding

结局指标

主要结局

Safety of ESD under SA

时间窗: periprocedurally

Safety was evaluated intra- and post-procedurally by recording anesthesia-related adverse events (ARAEs). Major ARAEs included death, anaphylaxis and severe cardiorespiratory or neurologic AEs. Minor ARAEs included any other cardiorespiratory or neurologic AEs, headache, acute urinary retention and itching.

Technical success of ESD under SA

时间窗: Immediately after the procedure

Technical success was defined as completion of the ESD under SA without the need of conversion to deep sedation or general anesthesia.

次要结局

  • Median ESD duration(Immediately after the procedure)
  • Length of hospital stay(At delivery)
  • Intra- and post-procedural need for additional opioid or other analgesic drug administration(periprocedurally)
  • ESD- and colonoscopy-related AEs(periprocedurally)

研究者

发起方
Azienda USL Modena
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Mauro Manno

Directore Gastroenterology and Endoscopy Unit

Azienda USL Modena

研究点 (1)

Loading locations...

相似试验